← Open Payments lookup

STACEY RYDZEWSKA: Open Payments

NPI 1437778677 · FARMINGTON, CT. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.

See the full provider profile for registry, prescribing and billing details.

Industry payments (Sunshine Act)

Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.

$1,902 in 88 payments from 17 companies in 2025. Trend: 2023 $0 · 2024 $98 · 2025 $1,902

Food & beverage: $1,902
CompanyPaymentsAmount
ABBVIE INC.23$353
Madrigal Pharmaceuticals6$266
Takeda Pharmaceuticals U.S.A., Inc.9$253
Salix Pharmaceuticals, a division of Bausch Health US, LLC10$213
Janssen Biotech, Inc.7$158
Ardelyx, Inc.6$136
Aimmune Therapeutics, Inc.5$134
Phathom Pharmaceuticals, Inc.9$107
Celltrion USA Inc.3$77
Regeneron Healthcare Solutions, Inc.2$44

Products named: REZDIFFRA, XIFAXAN, LINZESS, TREMFYA, IBSRELA, ZENPEP, RINVOQ, ENTYVIO.

Industry payments across CT — which companies pay providers there.